Note 19 - Operations and Industry Segments and Geographic Areas (Tables)

12 Months Ended

Sep. 29, 2012

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	2012			2011			2010
Net sales:
United States	$	67,981,932		$	50,721,211		$	50,632,653
Canada		7,920,424			1,275,494			1,535,861
Other		244,067			581,667			187,148
Total	$	76,146,423		$	52,578,372		$	52,355,662
Net sales:
Medical	$	46,452,008		$	34,741,164		$	35,572,689
Custom products		29,694,415			17,837,208			16,782,973
Total	$	76,146,423		$	52,578,372		$	52,355,662
Operating profit:
Medical	$	5,349,910		$	4,666,538		$	5,742,600
Custom products		2,797,465			1,518,916			1,628,106
Total		8,147,375			6,185,454			7,370,706
Corporate expense		(637,310	)		(710,281	)		(636,685	)
Other (expense) income		(44,092	)		18,893			52,194
Income from continuing operations before income taxes	$	7,465,973		$	5,494,066		$	6,786,215
Identifiable assets:
Medical	$	23,814,524		$	15,209,839		$	14,439,795
Custom products		9,030,782			7,097,568			6,016,135
Corporate		4,802,460			8,288,593			6,756,258
	$	37,647,766		$	30,596,000		$	27,212,188

Depreciation and amortization expenses:
Operating:
Medical	$	872,909	$	529,050	$	533,184
Custom products		336,114		280,381		279,636
Corporate		303		265		471
	$	1,209,326	$	809,696	$	813,291
Capital expenditures:
Medical	$	477,658	$	159,527	$	252,985
Custom products		206,669		31,682		17,591
	$	684,327	$	191,209	$	270,576